Advertisement

Topics

Morepen Labs consolidated net profit declines 4% in Q4

13:42 EDT 17 May 2018 | PharmaBiz

Morepen Laboratories, a Rs. 600 crore plus pharma and healthcare major, has suffered setback during the fourth quarter ended March 2018 despite lower interest cost.

Original Article: Morepen Labs consolidated net profit declines 4% in Q4

NEXT ARTICLE

More From BioPortfolio on "Morepen Labs consolidated net profit declines 4% in Q4"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...